Berapa harga Accelerate Diagnostics, Inc. (AXDX)

Harga Accelerate Diagnostics, Inc. (AXDX) adalah $0.01005

Apa kapitalisasi pasar Accelerate Diagnostics, Inc. (AXDX)

Kapitalisasi pasar Accelerate Diagnostics, Inc. (AXDX) adalah $146.42K

Accelerate Diagnostics, Inc. (AXDX) Dividen

Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms. The PhenoTest is specifically designed to yield crucial ID and AST results for patients suspected of bacteremia or fungemia – life-threatening conditions marked by high morbidity and mortality risks. Established in 1982, the company initially operated as Accelr8 Technology Corporation before adopting its current name, Accelerate Diagnostics, Inc., in December 2012. Its corporate headquarters are located in Tucson, Arizona.

Tahun	Dividen (disesuaikan dengan stock split)	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Dividen (disesuaikan dengan stock split)

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Tahun	Dividen	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Dividen

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Jumlah pembayaran dividen	Negara
Abbott Laboratories ABT.US	173.00%	US
Stryker Corporation SYK.US	85.00%	US
Medtronic plc MDT.US	178.00%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

Perusahaan

Jumlah pembayaran dividen

Negara